Hepatitis B virus pre‐S region: Clinical implications and applications
Authors:
- 12 December 2020
- journal article
- review article
- Published by Wiley in Reviews in Medical Virology
- Vol. 31 (4)
Abstract
Summary: Hepatitis B virus (HBV) infection is a major threat to global public health, which can result in many acute and chronic liver diseases. HBV, a member of the family Hepadnaviridae, is a small enveloped DNA virus containing a circular genome of 3.2 kb. Located upstream of the S‐open‐reading frame of the HBV genome is the pre‐S region, which is vital to the viral life cycle. The pre‐S region has high variability and many mutations in the pre‐S region are associated with several liver diseases, such as fulminant hepatitis (FH), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). In addition, the pre‐S region has been applied in the development of several pre‐S‐based materials and systems to prevent or treat HBV infection. In conclusion, the pre‐S region plays an essential role in the occurrence, diagnosis, and treatment of HBV‐related liver diseases, which may provide a novel perspective for the study of HBV infection and relevant diseases.Keywords
This publication has 126 references indexed in Scilit:
- Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donorsJournal of Hepatology, 2012
- DETECTION OF HEPATITIS B VIRUS PRES1 ANTIGEN USING A TIME-RESOLVED FLUOROIMMUNOASSAYJournal of Immunoassay and Immunochemistry, 2012
- Roles of the Envelope Proteins in the Amplification of Covalently Closed Circular DNA and Completion of Synthesis of the Plus-Strand DNA in Hepatitis B VirusJournal of Virology, 2011
- Association of Hepatitis B Virus Pre-S Deletions with the Development of Hepatocellular Carcinoma in Chronic Hepatitis BThe Journal of Infectious Diseases, 2011
- Hepatitis B virus genetic variability and evolutionVirus Research, 2007
- Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseasesJournal of Hepatology, 2004
- Efficacy and limitations of a specific immunotherapy in chronic hepatitis BJournal of Hepatology, 2001
- Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigensGene Therapy, 2000
- PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis BJournal of Hepatology, 1994
- Detection of antibodies against pre-S1 proteins in sera of patients with hepatitis B virus (HBV) infectionJournal of Hepatology, 1986